AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia
Authors: Vey, N Balatzentko, G LaFage, M Sainty, D Bouabdallah, R Chabannon, C Blaise, D Gastaut, JA Gabert, J
Citation: N. Vey et al., Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia, LEUK LYMPH, 42(5), 2001, pp. 945-952
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group
Authors: Jourdan, E Reiffers, J Stoppa, AM Sotto, JJ Attal, M Bouabdallaha, R Marit, G Fegueux, N Boulat, O Dastugue, N Boiron, JM Faberes, C Gastaut, JA Maraninchi, D Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials
Authors: Bouabdallah, R Stoppa, AM Coso, D Bardou, VJ Blaise, D Chabannon, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome
Authors: Michallet, M Bilger, K Garban, F Attal, M Huyn, A Blaise, D Milpied, N Moreau, P Bordigoni, P Kuentz, M Sadoun, A Cahn, JY Socie, G Thomas, X Arnaud, P Raus, N Lheritier, V Pigneux, A Boiron, JM
Citation: M. Michallet et al., Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome, J CL ONCOL, 19(14), 2001, pp. 3340-3349
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells
Authors: Tayebi, H Kuttler, F Saaa, P Lienard, A Petracca, B Lapierre, V Ferrand, C Fest, T Cahn, JY Blaise, D Kuentz, M Herve, P Tiberghien, P Robinet, E
Citation: H. Tayebi et al., Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells, EXP HEMATOL, 29(4), 2001, pp. 458-470
Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation
Authors: Tayebi, H Tiberghien, P Ferrand, C Lienard, A Duperrier, A Cahn, JY Lapierre, V Saas, P Kuentz, M Blaise, D Herve, P Robinet, E
Citation: H. Tayebi et al., Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation, BONE MAR TR, 27(2), 2001, pp. 167-175
Economic evaluation of blood stem-cells autologous transplantation
Authors: Le Corroller, AG Fortanier, C Faucher, C Blaise, D Moatti, JP
Citation: Ag. Le Corroller et al., Economic evaluation of blood stem-cells autologous transplantation, B CANCER, 88(9), 2001, pp. 893-899
Allogeneic hematopoietic cell transplantation in solid tumors
Authors: Bay, JO Choufi, B Tournilhac, O Faucher, C Blaise, D
Citation: Jo. Bay et al., Allogeneic hematopoietic cell transplantation in solid tumors, B CANCER, 88(9), 2001, pp. 900-907
Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft
Authors: Tayebi, H Lapierre, V Saas, P Lienard, A Sutton, L Milpied, N Attal, M Cahn, JY Kuentz, M Blaise, D Herve, P Tiberghien, P Robinet, E
Citation: H. Tayebi et al., Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft, BR J HAEM, 114(3), 2001, pp. 698-700
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies
Authors: Socie, G Clift, RA Blaise, D Devergie, A Ringden, O Martin, PJ Remberger, M Deeg, HJ Ruutu, T Michallet, M Sullivan, KM Chevret, S
Citation: G. Socie et al., Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies, BLOOD, 98(13), 2001, pp. 3569-3574
Influence of the hematopoietic stem cell source on early immunohematologicreconstitution after allogeneic transplantation
Authors: Lapierre, V Oubouzar, N Auperin, A Tramalloni, D Tayebi, H Robinet, E Kuentz, M Blaise, D Hartmann, O Herve, P Tiberghien, P
Citation: V. Lapierre et al., Influence of the hematopoietic stem cell source on early immunohematologicreconstitution after allogeneic transplantation, BLOOD, 97(9), 2001, pp. 2580-2586
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
Authors: Blaise, D Maraninchi, D Michallet, M Reiffers, J Jouet, JP Milpied, N Devergie, A Attal, M Sotto, JJ Kuentz, M Ifrah, N Duriac, C Bordigoni, P Gratecos, N Guilhot, F Guyotat, D Gluckman, E Vernant, JP
Citation: D. Blaise et al., Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission, BLOOD, 97(11), 2001, pp. 3669-3671
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370
Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience
Authors: Chabannon, C Olivero, S Blaise, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience, CYTOK CELL, 6(2), 2000, pp. 97-108
Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission
Authors: Blaise, D Attal, M Reiffers, J Michallet, M Bellanger, C Pico, JL Stoppa, AM Payen, C Marit, G Bouabdallah, R Sotto, JJ Rossi, JF Brandely, M Hercend, T Maraninchi, D
Citation: D. Blaise et al., Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission, EUR CYTOKIN, 11(1), 2000, pp. 91-97
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle
Authors: Blaise, D Kuentz, M Fortanier, C Bourhis, JH Milpied, N Sutton, L Jouet, JP Attal, M Bordigoni, P Cahn, JY Boiron, JM Schuller, MP Moatti, JP Michalle, M
Citation: D. Blaise et al., Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle, J CL ONCOL, 18(3), 2000, pp. 537-546
Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
Authors: Michallet, M Thomas, X Vernant, JP Kuentz, M Socie, G Esperou-Bourdeau, H Milpied, N Blaise, D Rio, B Reiffers, J Jouet, JP Cahn, JY Bourhis, JH Lioure, B Leporrier, M Sotto, JJ Souillet, G Sutton, L Bordigoni, P Dreyfus, F Tilly, H Gratecos, N Attal, M Leprise, PY Demeocq, F Michel, G Buzyn, A Delmas-Marsalet, B Bernaudin, F Ifrah, N Sadoun, A Guyotat, D Cavazzana-Cavo, M Caillot, D De Revel, T Vannier, JP Baruchel, A Fegueux, N Tanguy, ML Thiebaut, A Belhabri, A Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
Authors: Bay, JO Choufi, B Pomel, C Dauplat, J Durando, X Tournilhac, O Travade, P Plagne, R Blaise, D
Citation: Jo. Bay et al., Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer, BONE MAR TR, 25(6), 2000, pp. 681-682
Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis
Authors: Reiffers, J Labopin, M Sanz, M Korbling, M Blaise, D De la Rubia, J Gorin, NC
Citation: J. Reiffers et al., Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis, BONE MAR TR, 25(11), 2000, pp. 1115-1119
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed
Authors: Ringden, O Labopin, M Gorin, NC Meloni, G Blaise, D Reiffers, J Carlson, K Fouillard, L Frassoni, F
Citation: O. Ringden et al., The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed, BONE MAR TR, 25(10), 2000, pp. 1053-1058
Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center
Authors: Bouabdallah, R Coso, D Costello, R Bardou, VJ Blaise, D Xerri, L Sainty, D Maraninchi, D Gastaut, JA
Citation: R. Bouabdallah et al., Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center, BONE MAR TR, 25(1), 2000, pp. 35-40
Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers
Authors: Gravis, G Viens, P Vey, N Blaise, D Stoppa, AM Olive, D Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991
Rescue of haemopoiesis by a combination of growth factors including stem-cell factor
Authors: Blaise, D Faucher, C Vey, N Caraux, J Maraninchi, D Chabannon, C
Citation: D. Blaise et al., Rescue of haemopoiesis by a combination of growth factors including stem-cell factor, LANCET, 356(9238), 2000, pp. 1325-1326
Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma - A case report
Authors: Granel, B Serratrice, J Swiader, L Horshowski, N Blaise, D Vey, N Metras, D Habib, G Disdier, P Weiller, PJ
Citation: B. Granel et al., Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma - A case report, CANCER, 89(10), 2000, pp. 2138-2143
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
Authors: Ringden, O Labopin, M Gorin, NC Schmitz, N Schaefer, UW Prentice, HG Bergmann, L Jouet, JP Mandelli, F Blaise, D Fouillard, L Frassoni, F
Citation: O. Ringden et al., Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?, BR J HAEM, 111(4), 2000, pp. 1130-1137
Risultati: 1-25 | 26-44